Compounds
| Product Name | Cat # | Size |
|---|---|---|
BQ-3020 | SPE-200 | 1 x 5 mg |
[Ala1,3,11,15] Endothelin-1 | SPE-240 | 1 x 5 mg |
IRL-1620 | SPE-220 | 1 x 5 mg |
Sarafotoxin S6b | SPE-160 | 1 x 0.1 mg |
-
Lyophilized Powder Lyophilized PowderThis product is freeze dried. All water molecules have been removed.
-
Bioassay Tested Bioassay TestedThis antibody has undergone quality control and has been approved by our professional team.
-
Shipped at Room Temp. Shipped at Room Temp.This lyophilized product is shipped at room temperature. Please see its certificate of analysis for further storage instructions.
-
100% Net Peptide 100% Net PeptideThis vial contains 100% net peptide content.
Sizes: 4 Vials
Last update: 03/09/2018
Alomone Labs is pleased to offer the Endothelin Receptor Agonist Explorer Kit (#EK-255). The Explorer Kit contains endothelin receptor agonists, ideal for screening purposes.
For research purposes only, not for human use
References
Scientific Background
The endothelin system is comprised of three active peptides, ET-1, 2, and 3, which are considered to be very powerful vasoconstrictive substances. In humans, endothelins mediate their actions via two specific G-Protein Coupled Receptors, ETAR and ETBR. Both ETAR and ETBR are present in heart and in human myocardium at similar levels.1,2
The endothelin receptors differ in their ligand specificity. While ETAR has varying affinities for the endothelin isoforms (ET-1 >ET-2>ET-3), ETBR shows no selective affinity.2,3 Subsequent studies have demonstrated the presence of endothelins in vascular as well as in non-vascular cells and tissues, having multiple biological activities.
References
- Boivin, B. et al. (2003) J. Biol.Chem. 278, 29153.
- Grant, K. et al. (2003) Br. J. Cancer. 88, 163.
- Davenport, A.P. (2002) Pharmacol. Rev. 54, 219.
- Asham, E. et al. (2001) Br. J. Cancer. 85, 1759.